SEK310.40
0.45% yesterday
Stockholm, May 20, 05:29 pm CET
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Swedish Orphan Biovitrum Stock price

SEK310.40
+47.40 18.02% 1M
+20.60 7.11% 6M
-7.00 2.21% YTD
+29.60 10.54% 1Y
+97.20 45.59% 3Y
+104.30 50.61% 5Y
+173.40 126.57% 10Y
Stockholm, Closing price Tue, May 20 2025
+1.40 0.45%
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Key metrics

Market capitalization SEK106.61b
Enterprise Value SEK119.64b
P/E (TTM) P/E ratio 26.89
EV/FCF (TTM) EV/FCF 16.45
EV/Sales (TTM) EV/Sales 4.56
P/S ratio (TTM) P/S ratio 4.06
P/B ratio (TTM) P/B ratio 2.73
Revenue growth (TTM) Revenue growth 13.38%
Revenue (TTM) Revenue SEK26.24b
EBIT (operating result TTM) EBIT SEK5.81b
Free Cash Flow (TTM) Free Cash Flow SEK7.27b
Cash position SEK997.00m
EPS (TTM) EPS SEK11.42
P/E forward 22.75
P/S forward 3.78
EV/Sales forward 4.24
Show more

Is Swedish Orphan Biovitrum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Swedish Orphan Biovitrum Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Swedish Orphan Biovitrum forecast:

12x Buy
86%
1x Hold
7%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Swedish Orphan Biovitrum forecast:

Buy
86%
Hold
7%
Sell
7%

Financial data from Swedish Orphan Biovitrum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
26,237 26,237
13% 13%
100%
- Direct Costs 9,249 9,249
5% 5%
35%
16,988 16,988
18% 18%
65%
- Selling and Administrative Expenses 3,911 3,911
2% 2%
15%
- Research and Development Expense 3,558 3,558
24% 24%
14%
9,519 9,519
25% 25%
36%
- Depreciation and Amortization 3,709 3,709
7% 7%
14%
EBIT (Operating Income) EBIT 5,810 5,810
40% 40%
22%
Net Profit 3,960 3,960
85% 85%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Swedish Orphan Biovitrum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceutical. The firm focuses on the hematology and immunology therapeutic areas. It also offers specialty treatments in the area of genetics and metabolism. The company was founded in 2001 and is headquartered in Solna, Sweden.

Head office Sweden
CEO Guido Oelkers
Employees 1,840
Founded 2001
Website www.sobi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today